---
title: "ATYR: Efzofitimod advances toward approval with a new phase III trial targeting restrictive sarcoidosis"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290879435.md"
description: "Revised summary:Efzofitimod showed quality of life improvements and a strong safety profile in pulmonary sarcoidosis, despite missing the primary steroid reduction endpoint. The next phase III trial will target a sicker population with forced vital capacity as the primary endpoint, aiming for approval and expansion to other interstitial lung diseases.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-06-25T20:55:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290879435.md)
  - [en](https://longbridge.com/en/news/290879435.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290879435.md)
generator: "portal-rs"
---

# ATYR: Efzofitimod advances toward approval with a new phase III trial targeting restrictive sarcoidosis

Revised summary:  
Efzofitimod showed quality of life improvements and a strong safety profile in pulmonary sarcoidosis, despite missing the primary steroid reduction endpoint. The next phase III trial will target a sicker population with forced vital capacity as the primary endpoint, aiming for approval and expansion to other interstitial lung diseases.

Based on 

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [ATYR.US](https://longbridge.com/en/quote/ATYR.US.md)

## Related News & Research

- [aTyr Pharma submits Phase 3 efzofitimod trial protocol to FDA for pulmonary sarcoidosis study](https://longbridge.com/en/news/295273060.md)
- [3 Next-Gen AI Stocks That 3G Capital Bought in Q2](https://longbridge.com/en/news/296496173.md)
- [11:25 ETILD Day 2026 Spotlights Precision Medicine's Potential to Transform Patient Care](https://longbridge.com/en/news/296512797.md)
- [Why Wolfe Research Just Named Nvidia Stock Its Top AI Pick](https://longbridge.com/en/news/296822517.md)
- [You've all heard AI is remaking the economy. Here's how it's changing lives - for better or worse.](https://longbridge.com/en/news/296495661.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**